BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yurekli BP, Aksoy DY, Aybar M, Egesel T, Gurgey A, Hascelik G, Kirazli S, Haznedaroglu IC, Arslan S. The search for a common thrombophilic state during the active state of inflammatory bowel disease. J Clin Gastroenterol. 2006;40:809-813. [PMID: 17016137 DOI: 10.1097/01.mcg.0000225603.33481.56] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Ferrer I, Benavent G, Bastida G, Arnau MÁ, Iborra M, Beltrán B, Aguas M, Hinojosa J, Nos P. [Peripheral arterial thromboembolism in Crohn's disease]. Gastroenterol Hepatol 2013;36:30-4. [PMID: 22749513 DOI: 10.1016/j.gastrohep.2012.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Sipeki N, Davida L, Palyu E, Altorjay I, Harsfalvi J, Antal Szalmas P, Szabo Z, Veres G, Shums Z, Norman GL, Lakatos PL, Papp M. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn’s disease. World J Gastroenterol 2015; 21(22): 6952-6964 [PMID: 26078573 DOI: 10.3748/wjg.v21.i22.6952] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
3 Giannotta M, Tapete G, Emmi G, Silvestri E, Milla M. Thrombosis in inflammatory bowel diseases: what's the link? Thromb J. 2015;13:14. [PMID: 25866483 DOI: 10.1186/s12959-015-0044-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
4 Scaldaferri F, Lancellotti S, Pizzoferrato M, Cristofaro RD. Haemostatic system in inflammatory bowel diseases: New players in gut inflammation. World J Gastroenterol 2011; 17(5): 594-608 [PMID: 21350708 DOI: 10.3748/wjg.v17.i5.594] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
5 Robison NJ, Dawlabani N, Lastra CR, Dhall G. Cerebral sinus thrombosis in a child with active ulcerative colitis and factor V Leiden. Pediatr Blood Cancer 2009;52:867-9. [DOI: 10.1002/pbc.21967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
6 Lipinski S, Bremer L, Lammers T, Thieme F, Schreiber S, Rosenstiel P. Coagulation and inflammation. Molecular insights and diagnostic implications. Hamostaseologie. 2011;31:94-102, 104. [PMID: 21152678 DOI: 10.5482/ha-1134] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
7 Magro F, Soares JB, Fernandes D. Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World J Gastroenterol 2014; 20(17): 4857-4872 [PMID: 24803797 DOI: 10.3748/wjg.v20.i17.4857] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
8 Joshi D, Dickel T, Aga R, Smith-Laing G. Stroke in inflammatory bowel disease: a report of two cases and review of the literature. Thromb J 2008;6:2. [PMID: 18358077 DOI: 10.1186/1477-9560-6-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
9 Zhong M, Dong XW, Zheng Q, Tong JL, Ran ZH. Factor V Leiden and thrombosis in patients with inflammatory bowel disease (IBD): a meta-analysis. Thromb Res. 2011;128:403-409. [PMID: 21831411 DOI: 10.1016/j.thromres.2011.07.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
10 Maher MM, Soloma SH. Assessment of thrombophilic abnormalities during the active state of inflammatory bowel disease. Saudi J Gastroenterol. 2008;14:192-197. [PMID: 19568537 DOI: 10.4103/1319-3767.41743] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
11 Szakács Z, Csiszár B, Kenyeres P, Sarlós P, Erőss B, Hussain A, Nagy Á, Kőszegi B, Veczák I, Farkas N, Bódis E, Márta K, Szentesi A, Tőkés-Füzesi M, Berki T, Vincze Á, Tóth K, Hegyi P, Bajor J. Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case-control study protocol. BMJ Open 2019;9:e026315. [PMID: 30904871 DOI: 10.1136/bmjopen-2018-026315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Kohoutova D, Pecka M, Cihak M, Cyrany J, Maly J, Bures J. Prevalence of hypercoagulable disorders in inflammatory bowel disease. Scand J Gastroenterol 2014;49:287-94. [PMID: 24328909 DOI: 10.3109/00365521.2013.870597] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
13 Joshi D, Dickel T, Aga R, Smith-Laing G. Stroke in inflammatory bowel disease: a report of two cases and review of the literature. Thromb J. 2008;6:2. [PMID: 18358077 DOI: 10.1186/1477.9560-6-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Cakal B, Gokmen A, Yalinkilic M, Cakal E, Ayaz S, Nadir I, Ozin Y, Dagli U, Ulker A. Natural anticoagulant protein levels in Turkish patients with inflammatory bowel disease. Blood Coagulation & Fibrinolysis 2010;21:118-21. [DOI: 10.1097/mbc.0b013e328335d025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]